This cohort study compares the short- and long-term outcomes of bariatric surgery, with a specific focus on the rate of remission of type 2 diabetes in patients with early- and late-onset type 2 diabetes.
This cohort study reports that bariatric surgery increases the chance for remission of type 2 diabetes mellitus.
This cohort study compares the 5-year efficacy of gastrointestinal metabolic surgery vs medical treatment for type 2 diabetes mellitus in mildly obese patients.
This randomized clinical trial reports that bariatric surgery with 2 years of an adjunctive low-level lifestyle intervention resulted in more disease remission than did lifestyle intervention alone for obese participants with type 2 diabetes mellitus.
This medical record review cites postoperative hyperglycemia is a meaningful predictor of outcomes in patients with major comorbidities undergoing open ventral hernia repair (VHR).
This review of findings discussed at a multidisciplinary workshop on bariatric surgery notes there is evidence showing that bariatric surgery results in greater weight loss than nonsurgical treatments. Finks and Dimick provide a related invited commentary.
Courcoulas et al determine feasibility of a randomized clinical trial and compare initial outcomes of bariatric surgery and a structured weight loss program for treating type 2 diabetes mellitus.
Halperin et al test the feasibility of methods to conduct a larger multisite trial to determine the long-term effect of Roux-en-Y gastric bypass surgery compared with an intensive diabetes medical and weight management program for type 2 diabetes in obese patients.
Padwal et al test the importance of body mass index as a mortality predictor, identify other important mortality predictors, and construct a new parsimonious mortality prediction rule in a population eligible for bariatric surgery.